Literature DB >> 27593447

Role of Stem Cells in Colorectal Cancer Progression and Prognostic and Predictive Characteristics of Stem Cell Markers in Colorectal Cancer.

Mikhail Fedyanin1, Popova Anna, Polyanskaya Elizaveta, Tjulandin Sergei.   

Abstract

In the last decade, an increasing number of studies on tumor stem cell theory stating that there is only a small fraction of tumor cells capable of inducing tumor growth have been published. These cells can not only differentiate into more mature tumor cells, but also can maintain their own pool, that is the capacity for self-renewal. There are distinct subpopulations of cells within a tumor that express different combinations of stem cell markers and have different functions. The following markers are typically considered as markers of colorectal adenocarcinoma stem cells: CD133, CD144, CD24, CD166, CD44, CD29, ALDH1, LGR5, and CXCR4. However, data on the role of cancer stem cells in the process of colorectal cancer progression, their prognostic and predictive role are lacking. Researches on the phenotype, molecular and functional properties of this tumor cell subpopulation in both primary site and metastases of colorectal cancer are of great interest because they can allow developing new diagnostic and therapeutic strategies in the future.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27593447     DOI: 10.2174/1574888x11666160905092938

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  8 in total

1.  [Culture and identification of tumor stem cells from surgically resected colorectal cancer tissues].

Authors:  Na Tang; Lue Zhou; Zhiqiang Cheng; Yongjian Deng; Yanqing Ding
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

2.  TYMS-TM4SF4 axis promotes the progression of colorectal cancer by EMT and upregulating stem cell marker.

Authors:  Fen Zhang; Jiecheng Ye; Wenjing Guo; Fenfen Zhang; Liyuan Wang; Anjia Han
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

3.  mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer.

Authors:  Ji Young Chang; Jae Hyun Kim; Joyeon Kang; Yehyun Park; Soo Jung Park; Jae Hee Cheon; Won Ho Kim; Hoguen Kim; Jae Jun Park; Tae Il Kim
Journal:  Yonsei Med J       Date:  2020-07       Impact factor: 2.759

4.  Deregulation of cancer-stem-cell-associated miRNAs in tissues and sera of colorectal cancer patients.

Authors:  Cristiano Farace; Andrea Pisano; Carmen Griñan-Lison; Juan Antonio Marchal; Roberto Madeddu; Giuliana Solinas; Gema Jiménez; Marina Serra; Esmeralda Carrillo; Fabrizio Scognamillo; Federico Attene; Andrea Montella
Journal:  Oncotarget       Date:  2020-01-14

5.  Molecular features and gene expression signature of metastatic colorectal cancer (Review).

Authors:  Martina Poturnajova; Tatiana Furielova; Sona Balintova; Silvia Schmidtova; Lucia Kucerova; Miroslava Matuskova
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

Review 6.  Stemness, Inflammation and Epithelial-Mesenchymal Transition in Colorectal Carcinoma: The Intricate Network.

Authors:  Inese Briede; Dainis Balodis; Janis Gardovskis; Ilze Strumfa
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

7.  The Effect of Metformin on the Proliferation, Apoptosis and CD133 mRNA Expression of Colon Cancer Stem Cells by Upregulation of miR 342-3p.

Authors:  Yaqin Zhang; Ruofei Chen; Lili Deng; Zongwen Shuai; Mingwei Chen
Journal:  Drug Des Devel Ther       Date:  2021-11-11       Impact factor: 4.162

8.  MRI assessment of glutamine uptake correlates with the distribution of glutamine transporters and cancer stem cell markers.

Authors:  Yoojeong Seo; Joyeon Kang; Tae Il Kim; Chan Gyu Joo
Journal:  Sci Rep       Date:  2022-04-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.